Evaluation  ||| S:0 E:11 ||| NN
of  ||| S:11 E:14 ||| IN
neuromuscular  ||| S:14 E:28 ||| JJ
electrical  ||| S:28 E:39 ||| JJ
stimulation  ||| S:39 E:51 ||| NN
on  ||| S:51 E:54 ||| IN
fibre  ||| S:54 E:60 ||| JJ
characteristics  ||| S:60 E:76 ||| NNS
and  ||| S:76 E:80 ||| CC
oxidative  ||| S:80 E:90 ||| JJ
capacity  ||| S:90 E:99 ||| NN
in  ||| S:99 E:102 ||| IN
equine  ||| S:102 E:109 ||| FW
skeletal  ||| S:109 E:118 ||| FW
muscles  ||| S:118 E:126 ||| FW
Neuromuscular  ||| S:126 E:140 ||| FW
electrical  ||| S:140 E:151 ||| FW
stimulation  ||| S:151 E:163 ||| FW
( ||| S:163 E:164 ||| -LRB-
NMES ||| S:164 E:168 ||| NNP
)  ||| S:168 E:170 ||| -RRB-
is  ||| S:170 E:173 ||| VBZ
used  ||| S:173 E:178 ||| VBN
to  ||| S:178 E:181 ||| TO
increase  ||| S:181 E:190 ||| VB
or  ||| S:190 E:193 ||| CC
maintain  ||| S:193 E:202 ||| VB
muscle  ||| S:202 E:209 ||| JJ
strength  ||| S:209 E:218 ||| NN
during  ||| S:218 E:225 ||| IN
rehabilitation ||| S:225 E:239 ||| NN
.  ||| S:239 E:241 ||| .
Human  ||| S:241 E:247 ||| JJ
studies  ||| S:247 E:255 ||| NNS
investigating  ||| S:255 E:269 ||| VBG
different  ||| S:269 E:279 ||| JJ
protocols  ||| S:279 E:289 ||| NNS
show  ||| S:289 E:294 ||| VBP
that  ||| S:294 E:299 ||| IN
some  ||| S:299 E:304 ||| DT
treatments  ||| S:304 E:315 ||| JJ
induce  ||| S:315 E:322 ||| JJ
changes  ||| S:322 E:330 ||| NNS
in  ||| S:330 E:333 ||| IN
muscle  ||| S:333 E:340 ||| NN
characteristics ||| S:340 E:355 ||| NNS
.  ||| S:355 E:357 ||| .
Despite  ||| S:357 E:365 ||| IN
the  ||| S:365 E:369 ||| DT
frequent  ||| S:369 E:378 ||| JJ
use  ||| S:378 E:382 ||| NN
of  ||| S:382 E:385 ||| IN
NMES  ||| S:385 E:390 ||| NNP
in  ||| S:390 E:393 ||| IN
horses ||| S:393 E:399 ||| NNS
,  ||| S:399 E:401 ||| ,
no  ||| S:401 E:404 ||| DT
studies  ||| S:404 E:412 ||| NNS
have  ||| S:412 E:417 ||| VBP
been  ||| S:417 E:422 ||| VBN
published  ||| S:422 E:432 ||| VBN
describing  ||| S:432 E:443 ||| VBG
its  ||| S:443 E:447 ||| PRP$
efficacy ||| S:447 E:455 ||| NN
.  ||| S:455 E:457 ||| .
To  ||| S:457 E:460 ||| TO
investigate  ||| S:460 E:472 ||| VB
the  ||| S:472 E:476 ||| DT
effects  ||| S:476 E:484 ||| NNS
of  ||| S:484 E:487 ||| IN
a  ||| S:487 E:489 ||| DT
NMES  ||| S:489 E:494 ||| NNP
protocol  ||| S:494 E:503 ||| NN
on  ||| S:503 E:506 ||| IN
equine  ||| S:506 E:513 ||| JJ
fibre  ||| S:513 E:519 ||| JJ
types  ||| S:519 E:525 ||| NNS
and  ||| S:525 E:529 ||| CC
areas ||| S:529 E:534 ||| NNS
,  ||| S:534 E:536 ||| ,
glycogen  ||| S:536 E:545 ||| JJ
concentrations  ||| S:545 E:560 ||| NNS
and  ||| S:560 E:564 ||| CC
enzyme  ||| S:564 E:571 ||| JJ
activities ||| S:571 E:581 ||| NNS
.  ||| S:581 E:583 ||| .
NMES  ||| S:583 E:588 ||| NNP
was  ||| S:588 E:592 ||| VBD
administrated  ||| S:592 E:606 ||| VBN
to  ||| S:606 E:609 ||| TO
m.  ||| S:609 E:612 ||| CD
gluteus  ||| S:612 E:620 ||| CD
medius  ||| S:620 E:627 ||| NNS
and  ||| S:627 E:631 ||| CC
m.  ||| S:631 E:634 ||| CD
longissimus  ||| S:634 E:646 ||| JJ
dorsi ||| S:646 E:651 ||| NN
,  ||| S:651 E:653 ||| ,
on  ||| S:653 E:656 ||| IN
one  ||| S:656 E:660 ||| CD
side  ||| S:660 E:665 ||| NN
of  ||| S:665 E:668 ||| IN
6  ||| S:668 E:670 ||| CD
healthy  ||| S:670 E:678 ||| JJ
Standardbred  ||| S:678 E:691 ||| JJ
horses ||| S:691 E:697 ||| NNS
.  ||| S:697 E:699 ||| .
The  ||| S:699 E:703 ||| DT
contralateral  ||| S:703 E:717 ||| JJ
side  ||| S:717 E:722 ||| NN
of  ||| S:722 E:725 ||| IN
each  ||| S:725 E:730 ||| DT
muscle  ||| S:730 E:737 ||| NN
served  ||| S:737 E:744 ||| VBN
as  ||| S:744 E:747 ||| IN
a  ||| S:747 E:749 ||| DT
nonstimulated  ||| S:749 E:763 ||| JJ
control ||| S:763 E:770 ||| NN
.  ||| S:770 E:772 ||| .
The  ||| S:772 E:776 ||| DT
horses  ||| S:776 E:783 ||| NNS
were  ||| S:783 E:788 ||| VBD
stimulated  ||| S:788 E:799 ||| VBN
at  ||| S:799 E:802 ||| IN
50  ||| S:802 E:805 ||| CD
Hz  ||| S:805 E:808 ||| CD
a  ||| S:808 E:810 ||| DT
day ||| S:810 E:813 ||| NN
,  ||| S:813 E:815 ||| ,
with  ||| S:815 E:820 ||| IN
21-39  ||| S:820 E:826 ||| NNP
mA ||| S:826 E:828 ||| NNP
,  ||| S:828 E:830 ||| ,
for  ||| S:830 E:834 ||| IN
45-60  ||| S:834 E:840 ||| CD
min ||| S:840 E:843 ||| NN
,  ||| S:843 E:845 ||| ,
5  ||| S:845 E:847 ||| CD
days  ||| S:847 E:852 ||| NNS
a  ||| S:852 E:854 ||| DT
week  ||| S:854 E:859 ||| NN
for  ||| S:859 E:863 ||| IN
4  ||| S:863 E:865 ||| CD
weeks ||| S:865 E:870 ||| NNS
.  ||| S:870 E:872 ||| .
Needle  ||| S:872 E:879 ||| JJ
biopsies  ||| S:879 E:888 ||| NNS
were  ||| S:888 E:893 ||| VBD
obtained  ||| S:893 E:902 ||| VBN
from  ||| S:902 E:907 ||| IN
the  ||| S:907 E:911 ||| DT
muscles  ||| S:911 E:919 ||| NN
on  ||| S:919 E:922 ||| IN
both  ||| S:922 E:927 ||| DT
sides  ||| S:927 E:933 ||| NNS
before  ||| S:933 E:940 ||| IN
and  ||| S:940 E:944 ||| CC
after  ||| S:944 E:950 ||| IN
the  ||| S:950 E:954 ||| DT
experimental  ||| S:954 E:967 ||| JJ
period ||| S:967 E:973 ||| NN
.  ||| S:973 E:975 ||| .
Muscle  ||| S:975 E:982 ||| NN
samples  ||| S:982 E:990 ||| NNS
were  ||| S:990 E:995 ||| VBD
analysed  ||| S:995 E:1004 ||| VBN
for  ||| S:1004 E:1008 ||| IN
fibre  ||| S:1008 E:1014 ||| JJ
type  ||| S:1014 E:1019 ||| NN
proportions  ||| S:1019 E:1031 ||| NNS
and  ||| S:1031 E:1035 ||| CC
area  ||| S:1035 E:1040 ||| NN
using  ||| S:1040 E:1046 ||| VBG
histochemical  ||| S:1046 E:1060 ||| JJ
methods  ||| S:1060 E:1068 ||| NNS
and  ||| S:1068 E:1072 ||| CC
for  ||| S:1072 E:1076 ||| IN
glycogen  ||| S:1076 E:1085 ||| NN
and  ||| S:1085 E:1089 ||| CC
enzyme  ||| S:1089 E:1096 ||| JJ
activities  ||| S:1096 E:1107 ||| NNS
( ||| S:1107 E:1108 ||| -LRB-
citrate  ||| S:1108 E:1116 ||| FW
synthase ||| S:1116 E:1124 ||| FW
,  ||| S:1124 E:1126 ||| ,
3-OH-acyl  ||| S:1126 E:1136 ||| CD
CoA  ||| S:1136 E:1140 ||| JJ
dehydrogenase ||| S:1140 E:1153 ||| NN
,  ||| S:1153 E:1155 ||| ,
hexokinase  ||| S:1155 E:1166 ||| NN
and  ||| S:1166 E:1170 ||| CC
lactate  ||| S:1170 E:1178 ||| JJ
dehydrogenase ||| S:1178 E:1191 ||| NN
)  ||| S:1191 E:1193 ||| -RRB-
using  ||| S:1193 E:1199 ||| VBG
biochemical  ||| S:1199 E:1211 ||| JJ
methods ||| S:1211 E:1218 ||| NNS
.  ||| S:1218 E:1220 ||| .
Muscle  ||| S:1220 E:1227 ||| NN
contractions  ||| S:1227 E:1240 ||| NNS
at  ||| S:1240 E:1243 ||| IN
the  ||| S:1243 E:1247 ||| DT
location  ||| S:1247 E:1256 ||| NN
and  ||| S:1256 E:1260 ||| CC
depth  ||| S:1260 E:1266 ||| NN
of  ||| S:1266 E:1269 ||| IN
the  ||| S:1269 E:1273 ||| DT
muscle  ||| S:1273 E:1280 ||| NN
biopsy  ||| S:1280 E:1287 ||| NNS
were  ||| S:1287 E:1292 ||| VBD
confirmed  ||| S:1292 E:1302 ||| VBN
by  ||| S:1302 E:1305 ||| IN
diagnostic  ||| S:1305 E:1316 ||| JJ
ultrasound ||| S:1316 E:1326 ||| NN
.  ||| S:1326 E:1328 ||| .
Nonparametric  ||| S:1328 E:1342 ||| JJ
tests  ||| S:1342 E:1348 ||| NNS
( ||| S:1348 E:1349 ||| -LRB-
Mann-Whitney ||| S:1349 E:1361 ||| NNP
,  ||| S:1361 E:1363 ||| ,
Wilcoxon  ||| S:1363 E:1372 ||| NNP
sign-rank ||| S:1372 E:1381 ||| NNP
)  ||| S:1381 E:1383 ||| -RRB-
were  ||| S:1383 E:1388 ||| VBD
used  ||| S:1388 E:1393 ||| VBN
for  ||| S:1393 E:1397 ||| IN
statistical  ||| S:1397 E:1409 ||| JJ
analysis ||| S:1409 E:1417 ||| NN
.  ||| S:1417 E:1419 ||| .
No  ||| S:1419 E:1422 ||| DT
significant  ||| S:1422 E:1434 ||| JJ
differences  ||| S:1434 E:1446 ||| NNS
were  ||| S:1446 E:1451 ||| VBD
observed  ||| S:1451 E:1460 ||| VBN
in  ||| S:1460 E:1463 ||| IN
the  ||| S:1463 E:1467 ||| DT
percentage  ||| S:1467 E:1478 ||| NN
of  ||| S:1478 E:1481 ||| IN
types  ||| S:1481 E:1487 ||| NNS
I ||| S:1487 E:1488 ||| PRP
,  ||| S:1488 E:1490 ||| ,
IIA  ||| S:1490 E:1494 ||| NNP
or  ||| S:1494 E:1497 ||| CC
IIX  ||| S:1497 E:1501 ||| NNP
fibres ||| S:1501 E:1507 ||| NN
,  ||| S:1507 E:1509 ||| ,
fibre  ||| S:1509 E:1515 ||| JJ
areas ||| S:1515 E:1520 ||| NNS
,  ||| S:1520 E:1522 ||| ,
glycogen  ||| S:1522 E:1531 ||| JJ
levels  ||| S:1531 E:1538 ||| NNS
or  ||| S:1538 E:1541 ||| CC
enzyme  ||| S:1541 E:1548 ||| JJ
activities  ||| S:1548 E:1559 ||| NNS
either  ||| S:1559 E:1566 ||| CC
when  ||| S:1566 E:1571 ||| WRB
comparing  ||| S:1571 E:1581 ||| JJ
stimulated  ||| S:1581 E:1592 ||| NN
and  ||| S:1592 E:1596 ||| CC
nonstimulated  ||| S:1596 E:1610 ||| JJ
muscles  ||| S:1610 E:1618 ||| NNS
before  ||| S:1618 E:1625 ||| IN
and  ||| S:1625 E:1629 ||| CC
after  ||| S:1629 E:1635 ||| IN
the  ||| S:1635 E:1639 ||| DT
NMES  ||| S:1639 E:1644 ||| NNP
treatment ||| S:1644 E:1653 ||| NN
,  ||| S:1653 E:1655 ||| ,
or  ||| S:1655 E:1658 ||| CC
when  ||| S:1658 E:1663 ||| WRB
comparing  ||| S:1663 E:1673 ||| VBG
the  ||| S:1673 E:1677 ||| DT
left  ||| S:1677 E:1682 ||| NN
and  ||| S:1682 E:1686 ||| CC
right  ||| S:1686 E:1692 ||| JJ
muscle  ||| S:1692 E:1699 ||| NN
samples ||| S:1699 E:1706 ||| NNS
.  ||| S:1706 E:1708 ||| .
The  ||| S:1708 E:1712 ||| DT
NMES  ||| S:1712 E:1717 ||| NNP
treatment  ||| S:1717 E:1727 ||| NN
was  ||| S:1727 E:1731 ||| VBD
well  ||| S:1731 E:1736 ||| RB
tolerated  ||| S:1736 E:1746 ||| VBN
by  ||| S:1746 E:1749 ||| IN
the  ||| S:1749 E:1753 ||| DT
horses ||| S:1753 E:1759 ||| NNS
,  ||| S:1759 E:1761 ||| ,
but  ||| S:1761 E:1765 ||| CC
the  ||| S:1765 E:1769 ||| DT
present  ||| S:1769 E:1777 ||| JJ
protocol  ||| S:1777 E:1786 ||| NN
did  ||| S:1786 E:1790 ||| VBD
not  ||| S:1790 E:1794 ||| RB
induce  ||| S:1794 E:1801 ||| VB
significant  ||| S:1801 E:1813 ||| JJ
muscle  ||| S:1813 E:1820 ||| NN
adaptations ||| S:1820 E:1831 ||| NN
.  ||| S:1831 E:1833 ||| .
Further  ||| S:1833 E:1841 ||| JJ
studies  ||| S:1841 E:1849 ||| NNS
are  ||| S:1849 E:1853 ||| VBP
needed  ||| S:1853 E:1860 ||| VBN
to  ||| S:1860 E:1863 ||| TO
describe  ||| S:1863 E:1872 ||| VB
the  ||| S:1872 E:1876 ||| DT
effect  ||| S:1876 E:1883 ||| NN
of  ||| S:1883 E:1886 ||| IN
more  ||| S:1886 E:1891 ||| RBR
intense  ||| S:1891 E:1899 ||| JJ
and ||| S:1899 E:1902 ||| CC
/ ||| S:1902 E:1903 ||| NNP
or  ||| S:1903 E:1906 ||| CC
prolonged  ||| S:1906 E:1916 ||| JJ
NMES  ||| S:1916 E:1921 ||| NNP
treatment  ||| S:1921 E:1931 ||| NN
protocols  ||| S:1931 E:1941 ||| NNS
on  ||| S:1941 E:1944 ||| IN
muscles  ||| S:1944 E:1952 ||| NNS
of  ||| S:1952 E:1955 ||| IN
healthy  ||| S:1955 E:1963 ||| JJ
horses ||| S:1963 E:1969 ||| NNS
,  ||| S:1969 E:1971 ||| ,
and  ||| S:1971 E:1975 ||| CC
to  ||| S:1975 E:1978 ||| TO
describe  ||| S:1978 E:1987 ||| VB
if  ||| S:1987 E:1990 ||| IN
stimulation  ||| S:1990 E:2002 ||| JJ
protocols  ||| S:2002 E:2012 ||| NNS
induce  ||| S:2012 E:2019 ||| VB
positive  ||| S:2019 E:2028 ||| JJ
changes  ||| S:2028 E:2036 ||| NNS
in  ||| S:2036 E:2039 ||| IN
atrophied  ||| S:2039 E:2049 ||| JJ
muscles ||| S:2049 E:2056 ||| NNS
.  ||| S:2056 E:2058 ||| .
